Science Explorer Back to mapMap
Discussion
Institution · Radiant Research (United States)

Most cited papers from Radiant Research (United States)

Radiant Research (United States)

What are the most cited papers from Radiant Research (United States)?

The most cited paper from Radiant Research (United States) is "Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes" (Steven E. Nissen, Taro Tsunoda, Emin Murat Tuzcu et al., 2003), with 1,710 citations. Next come "Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks" (1,651) and "Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women" (1,353).

Showing 50 of 60 papers. Every paper with more than 126 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes Steven E. Nissen, Taro Tsunoda, Emin Murat Tuzcu et al. · JAMA Open access 4 Nov 2003 1,710
2 Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks Stanley B. Cohen, Paul E. Emery, Maria Greenwald et al. · Arthritis & Rheumatism 31 Aug 2006 1,651
3 Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women Henry G. Bone, David J. Hosking, Jean‐Pierre Devogelaer et al. · New England Journal of Medicine Open access 17 Mar 2004 1,353
4 Denosumab in Postmenopausal Women with Low Bone Mineral Density Michael R. McClung, E. Michael Lewiecki, Stanley B. Cohen et al. · New England Journal of Medicine Open access 22 Feb 2006 1,225
5 Etanercept as Monotherapy in Patients with Psoriasis Craig L. Leonardi, JEROLD L. POWERS, Robert T. Matheson et al. · New England Journal of Medicine Open access 19 Nov 2003 1,188
6 Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial John C. Davis, Désirée M F M van der Heijde, Jürgen Braun et al. · Arthritis & Rheumatism Nov 2003 765
7 Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease Christopher Paul Cannon, Sukrut Shah, Hayes M. Dansky et al. · New England Journal of Medicine Open access 17 Nov 2010 758
8 Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes Mark C. Genovese, Joan M. Bathon, Richard W. Martin et al. · Arthritis & Rheumatism Jun 2002 741
9 Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia Christie Mitchell Ballantyne, John Houri, Alberto Notarbartolo et al. · Circulation 19 May 2003 687
10 Efficacy and safety of rilonacept (interleukin‐1 trap) in patients with cryopyrin‐associated periodic syndromes: Results from two sequential placebo‐controlled studies Hal M. Hoffman, Martin L. Throne, N. Amar et al. · Arthritis & Rheumatism 30 Jul 2008 584
11 Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives William Stephen Harris, Michael J. Miller, Ann P. Tighe et al. · Atherosclerosis 7 Jan 2008 553
12 Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia Claude Gagné, Harold Edward Bays, Stuart R. Weiss et al. · The American Journal of Cardiology Nov 2002 497
13 Review of receptor model fundamentals Ronald C. Henry, CHARLES W. LEWIS, Philip Karl Hopke et al. · Atmospheric Environment (1967) 1984 428
14 Effect of ACAT Inhibition on the Progression of Coronary Atherosclerosis Steven E. Nissen, Emin Murat Tuzcu, H. Bryan Brewer et al. · New England Journal of Medicine 22 Mar 2006 397
15 Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia Carlos A. Dujovne, Mark P. Ettinger, J. Frederick McNeer et al. · The American Journal of Cardiology Nov 2002 392
16 Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study Michael H. Davidson, Evan A. Stein, Harold Edward Bays et al. · Clinical Therapeutics Jul 2007 388
17 Mechanisms for the Hypotriglyceridemic Effect of Marine Omega-3 Fatty Acids Michael H. Davidson · The American Journal of Cardiology 27 May 2006 373
18 Alkylphenol ethoxylates in the environment Carter G. Naylor, James P. Mieure, William Joseph Adams et al. · Journal of the American Oil Chemists Society Jul 1992 331
19 Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study Reginster Jy, S. Adámi, Peter Laszlo Lakatos et al. · Annals of the Rheumatic Diseases Open access 9 Dec 2005 328
20 Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD E. Michael Lewiecki, Paul D. Miller, Michael R. McClung et al. · Journal of Bone and Mineral Research Open access 20 Aug 2007 321
21 Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies Harold Edward Bays, Paul B. Moore, Margaret Drehobl et al. · Clinical Therapeutics Aug 2001 313
22 Safety of extended treatment with anakinra in patients with rheumatoid arthritis R Fleischmann, J Tesser, M H Schiff et al. · Annals of the Rheumatic Diseases Open access 5 Jan 2006 309
23 A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss Anne W. Lucky, Daniel J. Piacquadio, Chérie M. Ditre et al. · Journal of the American Academy of Dermatology 20 Mar 2004 306
24 Once‐weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial Edward Clark Keystone, Michael H. Schiff, Joel M. Kremer et al. · Arthritis & Rheumatism Feb 2004 286
25 Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study For the Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America , Pierre Dominique Delmas, Robert R. Recker et al. · Osteoporosis International 7 Apr 2004 280
26 Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group Recommendations Michael H. Davidson, Kevin Carl Maki, Thomas A. Pearson et al. · The American Journal of Cardiology 6 Jul 2005 272
27 Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications Harold Edward Bays, Ann P. Tighe, Richard Sadovsky et al. · Expert Review of Cardiovascular Therapy Open access Mar 2008 264
28 Distance-Weighted Traffic Density in Proximity to a Home Is a Risk Factor for Leukemia and Other Childhood Cancers Robert L. Pearson, Howard Wachtel, Kristie L. Ebi · Journal of the Air & Waste Management Association Open access Feb 2000 247
29 Safety and efficacy of Implanon™, a single-rod implantable contraceptive containing etonogestrel Sidney Funk, Michael M. Miller, Daniel R. Mishell et al. · Contraception 26 Apr 2005 229
30 Efficacy and Safety of a Once-Daily Morphine Formulation in Chronic, Moderate-to-Severe Osteoarthritis Pain Jacques R. Caldwell, Ronald J. Rapoport, Jeffrey C. Davis et al. · Journal of Pain and Symptom Management Open access Apr 2002 221
31 The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent Emile R. Mohler, Christie Mitchell Ballantyne, Michael H. Davidson et al. · Journal of the American College of Cardiology Open access Apr 2008 209
32 Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study. Mark P. Ettinger, Thomas W Littlejohn, Sherwyn Leon Schwartz et al. · PubMed 9 Apr 2003 206
33 Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis Anthony B. Hodsman, David A. Hanley, Mark P. Ettinger et al. · The Journal of Clinical Endocrinology & Metabolism Open access Nov 2003 205
34 Tolevamer, a Novel Nonantibiotic Polymer, Compared with Vancomycin in the Treatment of Mild to Moderately Severe Clostridium difficile-Associated Diarrhea Thomas Louie, Jennifer Peppe, Chi‐Leung Watt et al. · Clinical Infectious Diseases Open access 13 Jul 2006 204
35 Fully embedded board-level guided-wave optoelectronic interconnects R.T. Chen, Lei Lin, Chulchae Choi et al. · Proceedings of the IEEE Jun 2000 203
36 Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults Sam Jackson et al. · Vaccine Open access 27 Dec 2017 196
37 Pharmacokinetics and Safety of Golimumab, a Fully Human Anti‐TNF‐α Monoclonal Antibody, in Subjects With Rheumatoid Arthritis Honghui Zhou, Haishan Jang, Roy Fleischmann et al. · The Journal of Clinical Pharmacology 23 Feb 2007 194
38 A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova® compared to Lovaza® in a pharmacokinetic single-dose evaluation) study Michael H Davidson, Judith Johnson, Michael W. Rooney et al. · Journal of clinical lipidology 24 Jan 2012 191
39 Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial Michel Farnier, Peter J.H. Jones, Randall Severance et al. · Atherosclerosis Open access 14 Nov 2015 190
40 Epidemiology of Musculoskeletal Injuries among High School Cross-Country Runners Mitchell J. Rauh, Thomas D. Koepsell, Frederick P. Rivara et al. · American Journal of Epidemiology Open access 23 Nov 2005 189
41 Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter Region Jim Gilbert, Julie A. Lekstrom-Himes, Debra D. Donaldson et al. · The American Journal of Cardiology 20 Jan 2011 185
42 Characterization of Landfill Gas Composition at the Fresh Kills Municipal Solid-Waste Landfill Bart M. Eklund, Eric P. Anderson, Barry L. Walker et al. · Environmental Science & Technology 18 Jun 1998 178
43 Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate Michael R. McClung, Robert R. Recker, Paul D. Miller et al. · Bone 25 Mar 2007 177
44 Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study Thierry Dervieux, D Furst, D O Lein et al. · Annals of the Rheumatic Diseases Open access 28 Jan 2005 176
45 Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis Robert R. Recker, Jacob Andreas Stakkestad, C. H. Chesnut et al. · Bone May 2004 173
46 Effects of an Oral Growth Hormone Secretagogue in Older Adults Heidi K. White, Charles D. Petrie, William H. Landschulz et al. · The Journal of Clinical Endocrinology & Metabolism Open access 27 Jan 2009 171
47 Aging Bone and Osteoporosis Mark P. Ettinger · Archives of Internal Medicine 13 Oct 2003 170
48 Comparison of Glucose Concentration in Interstitial Fluid, and Capillary and Venous Blood During Rapid Changes in Blood Glucose Levels Suresh N. Thennadil, Jessica L. Rennert, Brian J. Wenzel et al. · Diabetes Technology & Therapeutics Sep 2001 166
49 Safety of Aggressive Lipid Management Michael H. Davidson, Jennifer G. Robinson · Journal of the American College of Cardiology Open access 17 Apr 2007 164
50 Contribution of common polymorphisms in reduced folate carrier and ??-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis Thierry Dervieux, Joel M. Kremer, Diana Orentas Lein et al. · Pharmacogenetics Nov 2004 162

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.